# TransMedics Group, Inc. (TMDX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TMDX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 363.88M | $ 22.00M | $ -1.91M | $ 867.72M | $ 518.05M |
| 2025 | $ 619.97M | $ 194.84M | $ 136.78M | $ 469.69M | $ 473.10M |
| 2024 | $ 464.09M | $ 37.28M | $ -85.08M | $ 518.29M | $ 228.60M |
| 2023 | $ 261.26M | $ -27.06M | $ -178.27M | $ 515.95M | $ 137.20M |
| 2022 | $ 104.40M | $ -40.47M | $ -64.48M | $ 67.56M | $ 187.38M |
| 2021 | $ 35.97M | $ -52.56M | $ -38.49M | $ 43.80M | $ 67.85M |
| 2020 | $ 32.66M | $ -36.62M | $ -39.14M | $ 34.66M | $ 103.89M |
| 2019 | $ 30.47M | $ -43.30M | $ -41.89M | $ 34.15M | $ 54.65M |
| 2018 | $ 17.19M | $ -31.37M | $ -34.87M | $ 33.67M | $ -4.83M |
| 2017 | $ 10.86M | $ -28.13M | $ -31.47M | $ 8.65M | $ 18.15M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.67 |
| Liabilities / Eq | 1.83 |
| Current Ratio | 6.62 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 781.88 |

## Other views

- [Metrics](https://sponda.capital/en/TMDX.md)
- [Charts](https://sponda.capital/en/TMDX/charts.md)
- [Compare](https://sponda.capital/en/TMDX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.